← Eichor
Study identifier: NCT07245979 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Supplementation With Sirtuin Activators in Women With Increased Body Weight

Condition: Obesity & Overweight  ·  Sponsor: Poznan University of Life Sciences

PhaseNA
Planned participants120
Who can joinFemale, 40 Years to 65 Years
Healthy volunteersYes

About this study

The goal of this clinical trial is to learn if the six-month supplementation with sirtuin activators can affect metabolism in 40-to-65-year old women with increased body weight. The main questions it aims to answer are: Does sirtuin activators affect lipid and carbohydrate metabolism? Does sirtuin activators affect oxydative stress, immune functions and cell ageing? Researchers will compare sirtuin activators to a placebo (a look-alike substance that contains no drug) to see if drug sirtuin activators works to improve metabolic status. Participants will: Take sirtuin activators or a placebo every day for 6 months. Visit the university once every 3 months for checkups and tests.

This description comes directly from the study's public registry record.

Talk to the study team

Agata Chmurzynska, Professor  ·  +486184661  ·  agata.chmurzynska@up.poznan.pl

Always discuss trial participation with your own doctor first.

Locations (1)

Poznan University of Life SciencesPoznan, PolandRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07245979